89943-00-0 Usage
Uses
Used in Pharmaceutical Industry:
2-cyclobutyl-1H-imidazole is utilized as a key intermediate in the synthesis of various pharmaceuticals due to its unique structural and chemical properties. Its ability to be incorporated into complex organic molecules contributes to the development of new drugs with potential therapeutic benefits.
Used in Agrochemical Industry:
In the agrochemical sector, 2-cyclobutyl-1H-imidazole serves as a crucial building block for the preparation of agrochemicals. Its role in the synthesis of these compounds aids in the creation of products that can enhance crop protection and yield.
Used in Organic Synthesis:
2-cyclobutyl-1H-imidazole is employed as a versatile intermediate in organic synthesis for the preparation of a wide range of complex organic molecules. Its structural features make it an ideal candidate for the construction of diverse chemical entities with potential applications in various fields.
Used in Research and Development:
2-cyclobutyl-1H-iMidazole is also used in research and development settings for the investigation of its potential therapeutic applications. Studies are being conducted to explore its efficacy in the treatment of various health conditions, including cancer, inflammation, and neurological disorders, with the aim of discovering new treatment options and improving patient outcomes.
Check Digit Verification of cas no
The CAS Registry Mumber 89943-00-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,9,9,4 and 3 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 89943-00:
(7*8)+(6*9)+(5*9)+(4*4)+(3*3)+(2*0)+(1*0)=180
180 % 10 = 0
So 89943-00-0 is a valid CAS Registry Number.
89943-00-0Relevant academic research and scientific papers
Compounds and Compositions as Protein Kinase Inhibitors
-
, (2011/04/14)
The present invention provides compounds of Formula I or II: wherein R1, R1b, R2, R3, R4, R5, R6 and R7 are defined herein. The compounds of Formula (I) or (II) and pharmaceutical compositions thereof are useful for the treatment of B-Raf-associated diseases.
